Your donation will make a difference:
Cystic Fibrosis Trust
Forum

Campaigning in your region

Take a look at how we're campaigning for access to precision medicines in England, Northern Ireland, Scotland and Wales, and find out how you can share your voice.

England
Northern Ireland
Scotland
Wales

England

On Thursday 24 October, NHS England has announced that people with cystic fibrosis (CF) living in England who stand to benefit from life-saving drugs Orkambi and Symkevi will receive them as part of a two-year managed access agreement with the manufacturer, Vertex Pharmaceuticals. Find out more about this deal, or look at our frequently asked questions.

Northern Ireland

The Department of Health in Northern Ireland confirmed its intention to complete a deal with Vertex Pharmaceuticals to make life-saving drugs Orkambi and Symkevi available to eligible people with cystic fibrosis (CF) living in Northern Ireland. Richard Pengelly, Permanent Secretary of the Department of Health in Northern Ireland, announced on 12 November that a formal agreement with Vertex Pharmaceuticals will be finalised and signed in the very near future, and that clinicians will be able to begin prescribing the drugs to the first eligible patients within the next few weeks. 

Scotland

On 12 September 2019, the Scottish Government reached an agreement with Vertex with support from the UK CF Registry and announced a five-year deal that will see access to Orkambi and Symkevi for everyone with cystic fibrosis in Scotland who stand to benefit from the drugs.

Wales

On 13 November, the Welsh Minister for Health and Social Services, Vaughan Gething, announced that the Welsh Government has agreed terms in principle with Vertex Pharmaceuticals to make Orkambi and Symkevi available alongside Kalydeco in Wales. We await further confirmation on the details of this deal but understand that the Government aims to have it finalised by the end of November and intends to begin to roll out access where clinically appropriate to eligible patients the following month.


For the latest news on our Stopping the Clock campaign and other updates in the CF community, sign up to receive our e-newsletter.


Research we fund

We fund research to tackle some of the most pressing issues in CF today. Find out how your donations are making a difference.

What is CF?

Cystic fibrosis, or CF, affects the lungs, digestive system and other organs, and there are around 10,500 people living with it in the UK.

Contact us

Get in touch with us to speak to someone on our Helpline, found out about an event or speak to our Press Team.